Trial Outcomes & Findings for Community-Based Detection and Treatment of Peripheral Arterial Disease in Hispanics. (NCT NCT01440634)
NCT ID: NCT01440634
Last Updated: 2015-12-29
Results Overview
Walking distance (Six-Minute Walk test). Following a standardized protocol, individuals are instructed to walk back and forth a 100-ft hallway as far as they can in six minutes after instructions to cover as much distance as possible. A research assistant walks slightly behind each participant so as not to pace the individual. The research assistant records whether or not each person stops during the 6-minute walk. During the proposed study, members of the research team and trained lay health promoters (LHPs) will walk directly behind the individuals and give standardized instructions of encouragement at set intervals. Data will be reported on meters walked.
COMPLETED
NA
347 participants
6 months
2015-12-29
Participant Flow
Patients were recruited at community centers. Enrollment was performed between february 2008 and June 2011.
Patients that denied to be randomized and/or to follow the schedule for the research procedures was excluded of the study.
Participant milestones
| Measure |
Supervised Exercise
It consists of six months of supervised, intermittent track walking to near maximal leg pain or discomfort three days per week. Walking duration will begin at 20 - 30 minutes per session for the first month of the program, and increased by 5 minutes per session per month until a total of 45 minutes of walking per session is reached by the third month.
|
Standard of Care
Patients will be observed during the time of the study, no intervention will be applied. Patients are allowed to do their regular activity at home.
|
|---|---|---|
|
Cross Sectional Phase
STARTED
|
0
|
347
|
|
Cross Sectional Phase
COMPLETED
|
0
|
347
|
|
Cross Sectional Phase
NOT COMPLETED
|
0
|
0
|
|
Randomization Phase
STARTED
|
30
|
24
|
|
Randomization Phase
COMPLETED
|
24
|
14
|
|
Randomization Phase
NOT COMPLETED
|
6
|
10
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Community-Based Detection and Treatment of Peripheral Arterial Disease in Hispanics.
Baseline characteristics by cohort
| Measure |
Supervised Exercise
n=24 Participants
It consists of six months of supervised, intermittent track walking to near maximal leg pain or discomfort three days per week. Walking duration will begin at 20 - 30 minutes per session for the first month of the program, and increased by 5 minutes per session per month until a total of 45 minutes of walking per session is reached by the third month.
|
Standard of Care
n=14 Participants
Patients will be observed during the time of the study, no intervention will be applied. Patients are allowed to do their regular activity at home.
|
Total
n=38 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
24 Participants
n=5 Participants
|
14 Participants
n=7 Participants
|
38 Participants
n=5 Participants
|
|
Age, Continuous
|
75 years
n=5 Participants
|
79.5 years
INTER_QUARTILE_RANGE 11.08 • n=7 Participants
|
79.5 years
INTER_QUARTILE_RANGE 11.08 • n=5 Participants
|
|
Sex: Female, Male
Female
|
17 Participants
n=5 Participants
|
11 Participants
n=7 Participants
|
28 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
7 Participants
n=5 Participants
|
3 Participants
n=7 Participants
|
10 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
24 participants
n=5 Participants
|
14 participants
n=7 Participants
|
38 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 6 monthsWalking distance (Six-Minute Walk test). Following a standardized protocol, individuals are instructed to walk back and forth a 100-ft hallway as far as they can in six minutes after instructions to cover as much distance as possible. A research assistant walks slightly behind each participant so as not to pace the individual. The research assistant records whether or not each person stops during the 6-minute walk. During the proposed study, members of the research team and trained lay health promoters (LHPs) will walk directly behind the individuals and give standardized instructions of encouragement at set intervals. Data will be reported on meters walked.
Outcome measures
| Measure |
Supervised Exercise
n=30 Participants
It consists of six months of supervised, intermittent track walking to near maximal leg pain or discomfort three days per week. Walking duration will begin at 20 - 30 minutes per session for the first month of the program, and increased by 5 minutes per session per month until a total of 45 minutes of walking per session is reached by the third month.
|
Standard of Care
n=24 Participants
Patients will be observed during the time of the study, no intervention will be applied. Patients are allowed to do their regular activity at home.
|
|---|---|---|
|
Effect of an Exercise Intervention on Walking Ability (Functional Outcome)
|
301.4 meters
Standard Deviation 140.3
|
185.1 meters
Standard Deviation 164.1
|
Adverse Events
Supervised Exercise
Standard of Care
Serious adverse events
| Measure |
Supervised Exercise
n=30 participants at risk
It consists of six months of supervised, intermittent track walking to near maximal leg pain or discomfort three days per week. Walking duration will begin at 20 - 30 minutes per session for the first month of the program, and increased by 5 minutes per session per month until a total of 45 minutes of walking per session is reached by the third month.
|
Standard of Care
n=24 participants at risk
Patients will be observed during the time of the study, no intervention will be applied. Patients are allowed to do their regular activity at home.
|
|---|---|---|
|
General disorders
Death
|
3.3%
1/30 • Number of events 1
|
0.00%
0/24
|
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place